drugset / Trial / NCT05229536
Immunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 Months
RandomizedParallel-groupQuadruple-blindPrevention
Summary
The purpose of this study is to evaluate the immunogenicity and safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 35 years.
Timeline
- Start
- 2018-12-21
- Primary completion
- 2019-11-21
- Completion
- 2019-11-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Meningococcal ACYW135 Polysaccharide Conjugate Vaccine | Vaccine | 20 ug | Intramuscular |
| Subject | Meningococcal ACYW135 Polysaccharide Conjugate Vaccine | Vaccine | 40 ug | Intramuscular |